Cholesterol, LDL
Research News and Information

Monday, November 23, 2009

Overexpression of low-density lipoprotein receptor and lipid accumulation in intestinal polyps in Min mice.

29 Nov 2009 Apc-deficient Min mice feature low expression of lipoprotein lipase (LPL), high concentration of serum triglyceride (TG), fatty change of the liver and large numbers of intestinal polyps. We have reported that induction of LPL expression reduces ... Read more...

Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.

Nov 2009 OBJECTIVES: Our aim was to determine the effects of high-dose (2 g) nicotinic acid (NA) on progression of atherosclerosis and measures of vascular function. BACKGROUND: NA raises high-density lipoprotein cholesterol (HDL-C) and reduces low-density ... Read more...

Improving chronic care of type 2 diabetes using teams of interprofessional learners.

30 Oct 2009 PURPOSE: To improve the care and outcomes of adult patients with type 2 diabetes by teaching interprofessional teams of learners the principles and practices of the Improving Chronic Illness Care Model. METHOD: The study population consisted of 384 ... Read more...

Latest indexed articles for 'Cholesterol, LDL'

These are the very latest articles for this heading:

• Overexpression of low-density lipoprotein receptor and lipid accumulation in intestinal polyps in Min mice. 29 Nov 2009
• Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging. Nov 2009
• Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. Nov 2009
• Improving chronic care of type 2 diabetes using teams of interprofessional learners. 30 Oct 2009
• Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. 24 Oct 2009
• Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation. 4 Oct 2009
• Statins in acute coronary syndromes: do the guideline recommendations match the evidence? 4 Oct 2009
• The University of New Hampshire's Young Adult Health Risk Screening Initiative. 29 Sep 2009
• Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. 29 Sep 2009
• Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib. 29 Sep 2009
• Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study. 29 Sep 2009
• Mostly plants. 29 Sep 2009
• Effects of plant-based diets on plasma lipids. 29 Sep 2009
• Impact of coronary computed tomographic angiography findings on the medical treatment and control of coronary artery disease and its risk factors. 29 Sep 2009
• Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention. 27 Sep 2009
• Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: a comparison of subgroups by age. 26 Sep 2009
• Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus. 23 Sep 2009
• Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). 13 Sep 2009
• Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome. 13 Sep 2009
• [Lower and lower cholesterol targets increase adverse effects] 30 Aug 2009

See a longer list of these articles.

Technical information about 'Cholesterol, LDL'

Definition: Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol.

Registry Number: 0

Descriptor UI: D008078

Alternative terms: Cholesterol, LDL; Low Density Lipoprotein Cholesterol; beta-Lipoprotein Cholesterol; Cholesterol, beta-Lipoprotein; beta Lipoprotein Cholesterol; LDL Cholesterol; Cholesteryl Linoleate, LDL; LDL Cholesteryl Linoleate;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D10.532.515.500; D10.570.938.208.275; D12.776.521.550.500;

History Note: 2007 (1985)